F.D.A. Requires Stronger Warning Label for Xanax and Similar Drugs
The Food and Drug Administration said on Wednesday that it would require a new warning label on a class of common psychiatric drugs, called benzodiazepines, to better warn the public and health professionals about the serious risks of abuse and addiction. Benzodiazepines are prescribed for anxiety, insomnia, seizures, panic disorders and other health problems. They…